Browse the evidence

Metformin reduces hepatic glucose production primarily by inhibiting fructose-1,6-bisphosphatase (FBP1) via AMP-mediated allosteric inhibition, rather than solely through AMPK activation.

Metformin lowers blood sugar partly by directly inhibiting an enzyme (FBP1) in the liver that makes glucose, triggered by changes in cellular energy (AMP). This happens alongside its known effects on AMPK. For patients, this means metformin is effective through multiple pathways, which may explain its broad utility in type 2 diabetes management.

Obesity-associated hyperleptinemia promotes cancer progression through JAK2/STAT3, ERK, and PI3K/Akt signaling pathways, enhancing cell proliferation, angiogenesis, and anti-apoptosis.

For individuals with obesity, high levels of the hormone leptin can directly fuel cancer growth by stimulating cell division and survival. Managing body weight may help reduce these hormonal drivers, potentially lowering cancer risk and improving outcomes, especially for hormone-sensitive cancers.

Low levels of adiponectin, common in obesity, are associated with increased risk and progression of various cancers due to the loss of its anti-proliferative and pro-apoptotic effects.

Obesity often leads to low levels of adiponectin, a hormone that normally helps prevent cancer by stopping abnormal cell growth and promoting cell death. Maintaining a healthy weight can help keep adiponectin levels high, potentially reducing the risk of several cancers, including breast, colon, and endometrial cancer.

Inhibition of mTORC1 activity is a necessary physiological trigger for initiating autophagy during nutrient deprivation, which recycles cellular components to sustain blood glucose and amino acid levels.

Fasting works by turning off the 'growth' signal (mTORC1), which unlocks the body's internal recycling system (autophagy). This system breaks down old cellular parts to create glucose and amino acids, keeping you alive and healthy during food scarcity. You cannot have this benefit if your body is constantly in 'growth mode' due to constant eating.

Enhancing autophagy through genetic or pharmacological means improves glucose tolerance, insulin sensitivity, and resistance to obesity in high-fat diet models.

Boosting your body's natural cleanup processes (autophagy) can help you stay lean and sensitive to insulin, even if you eat a high-fat diet. This suggests that maintaining cellular health through fasting or exercise is as important as the food you eat.

Knocking out the ACC2 gene in mice increases continuous fat oxidation, which raises total energy expenditure and reduces fat mass without causing insulin resistance.

This research suggests that strategies which continuously promote fat oxidation (like specific genetic targets or metabolic states) can increase overall energy expenditure and reduce fat mass. However, this was achieved through genetic modification in mice, not a standard human intervention, so direct application requires caution.

Knocking out ACC2 improves insulin sensitivity in high-fat-fed mice by reducing intracellular diacylglycerol and novel PKC activity, thereby preventing fat-induced insulin resistance.

This mechanism suggests that reducing intracellular fat metabolites (like diacylglycerol) can improve insulin sensitivity even in the presence of high fat intake. This supports the idea that metabolic health is more about where fat is stored and oxidized than just total fat intake.

Eating frequency (number of meals/snacks per day) is not associated with the risk of incident coronary heart disease.

How many times you eat per day does not appear to affect your risk of heart disease. Focus on whether you skip breakfast or eat late at night, as these specific timing issues matter more than total meal frequency.

Physical exercise restores hypothalamic insulin and leptin sensitivity in obese rodents by suppressing IKKβ and ER stress through an IL-6-dependent mechanism that requires IL-10.

If you are overweight or obese, exercise does more than just burn calories; it helps reset your brain's sensitivity to hunger and fullness hormones (insulin and leptin). This happens through a specific inflammatory pathway involving IL-6 and IL-10. This suggests that regular physical activity can help overcome the biological drive to overeat that often accompanies obesity, making it easier to maintain a healthy weight.

In tertiary-care diabetic populations, comprehensive management of glycemic, lipid, and blood pressure targets (ABC control) remains suboptimal, with only 20.2% of patients achieving all preset control goals despite high medication availability.

For patients managing diabetes, simply having access to medication is not enough to guarantee health outcomes. This data suggests that achieving comprehensive control (blood sugar, lipids, and blood pressure) is difficult, with only 1 in 5 patients succeeding in a high-resource setting. Focus on the 'why' behind uncontrolled numbers, as medication availability alone does not solve the metabolic burden.

Chronic vascular complications, including retinopathy, nephropathy, neuropathy, and ischemic heart disease, are highly prevalent in diabetic populations, with over half of patients exhibiting at least one complication.

More than half of diabetic patients in this study had at least one chronic complication, such as eye, kidney, nerve, or heart issues. This highlights the critical importance of regular screening for complications, even if you feel healthy, as damage can be silent.

Financial strain is independently associated with decreased subjective sleep quality and lower sleep efficiency in midlife women, regardless of race.

If you are experiencing financial stress, expect your sleep to suffer. This is not a failure of willpower but a physiological response to stress. Prioritize stress management techniques alongside sleep hygiene, as the economic pressure itself is a direct disruptor of sleep efficiency.

African American midlife women exhibit worse sleep outcomes, including decreased slow wave sleep and increased cortical hyperarousal, compared to Caucasian women, independent of socioeconomic status.

African American women may face inherent physiological challenges in achieving deep sleep (slow wave sleep) and maintaining sleep continuity compared to Caucasian women. This is not a personal failing but a documented physiological difference that may require tailored sleep strategies and stress management.

Aerobic exercise does not significantly improve memory or executive function scores in early Alzheimer's disease compared to stretching and toning.

Do not expect aerobic exercise to directly reverse memory loss or improve executive function scores in early Alzheimer's. The primary benefit observed in this study was the maintenance of functional ability (ability to perform daily tasks). Exercise should be prescribed for functional preservation rather than cognitive enhancement.

In women with visceral obesity, skeletal muscle insulin resistance is caused by a diminished capacity for postabsorptive free fatty acid (FFA) utilization, rather than by glucose-FFA substrate competition.

For women with high visceral fat, insulin resistance is linked to their muscles' inability to efficiently use fat for energy when fasting, not necessarily to high fat intake causing competition with glucose. Improving the muscle's capacity to oxidize fat (e.g., through exercise which increases mitochondrial enzymes like CPT and citrate synthase) may be a key target for improving insulin sensitivity.

High-dose alpha-tocopherol and selenium supplementation failed to prevent prostate cancer and may increase risk, contradicting earlier observational studies.

Do not rely on high-dose alpha-tocopherol and selenium supplements to prevent prostate cancer. Current high-quality evidence suggests they are ineffective and may carry risks. Focus on a balanced diet rich in natural vitamin E sources instead.

A higher DNA methylation (DNAm) age relative to chronological age is significantly associated with increased all-cause mortality risk in older adults, independent of chronological age and familial factors.

Your biological age, as measured by DNA methylation patterns, is a stronger predictor of mortality than your calendar age, especially in old age. While you cannot directly 'dose' this biomarker, the study suggests that maintaining a DNAm age closer to or younger than your chronological age is associated with lower mortality risk. Focus on health-promoting behaviors known to influence epigenetic markers, such as managing stress, exercise, and nutrition, rather than fixating on the number itself.

Fecal microbiota transplantation (FMT) is a highly effective treatment for recurrent Clostridium difficile infection (CDI), achieving significantly higher symptom resolution rates compared to standard antibiotic therapies alone.

If you have recurrent C. diff infection that keeps coming back despite antibiotics, ask your doctor about Fecal Microbiota Transplantation (FMT). It involves receiving processed stool from a healthy donor, which has been shown to resolve symptoms in about 85% of cases, significantly better than antibiotics alone. While the idea might seem unappealing, it is a medically supervised procedure with rigorous donor screening to ensure safety.

Aging causes a redistribution of lipids from subcutaneous to visceral adipose tissue, leading to ectopic lipid storage, insulin resistance, and chronic low-grade systemic inflammation.

As you age, your body naturally shifts fat storage from under the skin to around your organs, which increases health risks. This shift is driven by hormonal changes and reduced activity of brown fat. While you can't stop aging, you can counteract these effects through regular exercise, weight management, and potentially medical interventions that improve insulin sensitivity, helping to maintain metabolic health and quality of life.

Declining brown adipose tissue (BAT) activity with age contributes to reduced energy expenditure and increased obesity risk, mediated by reduced sympathetic output and increased FOXA3 transcription factor.

Brown fat, which burns calories to generate heat, becomes less active as you age. This is partly due to reduced nerve signals and changes in gene expression. While you cannot easily reverse this biological change, maintaining physical activity may help stimulate remaining brown fat function.

Aging is associated with an increase in pro-inflammatory adipokines and a decline in anti-inflammatory adipokines, contributing to a chronic state of low-grade systemic inflammation known as 'inflammaging'.

As you age, your fat cells release more inflammatory signals and fewer protective ones, leading to chronic low-grade inflammation. This 'inflammaging' increases the risk of diseases like diabetes and heart disease. Managing weight and staying active can help modulate these inflammatory signals.

Obesity, insulin resistance, and type 2 diabetes are pathological conditions associated with exaggerated and prolonged postprandial lipemia, characterized by delayed clearance of triacylglycerol-rich lipoproteins (TRL).

If you have obesity, insulin resistance, or type 2 diabetes, your body may struggle to clear fat from your blood after meals, leading to higher and longer-lasting triglyceride levels. This delayed clearance is a significant risk factor for heart disease, even if your fasting cholesterol looks okay. Managing these conditions through lifestyle and medication can help improve postprandial lipid clearance.

Chronic systemic inflammation is a primary, malleable driver of mortality and functional decline (capability and cognition) in extreme old age (85+ years), whereas telomere length is not a predictor of successful aging in this demographic.

In extreme old age (85+), managing chronic inflammation is more critical for maintaining independence and longevity than focusing on telomere length. Since inflammation is a 'malleable driver,' strategies that reduce systemic inflammation (such as managing infections like CMV, maintaining metabolic health, and potentially using safe anti-inflammatory agents like melatonin) may help preserve cognitive function and physical capability. This is distinct from younger ages where other factors might dominate.

Obesity increases the risk of post-menopausal breast cancer primarily through increased bioavailability of oestrogens due to adipose tissue aromatization and reduced sex hormone-binding globulin (SHBG).

For post-menopausal women, maintaining a healthy weight is crucial for reducing breast cancer risk. This risk is driven by higher levels of bioavailable oestrogens. If you are not using hormone replacement therapy, weight management is a key protective factor.